These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38042968)

  • 1. Atorvastatin improves sputum conversion and chest X-ray severity score.
    Adewole OO; Omotoso BA; Ogunsina M; Aminu A; Ayoola O; Adedeji T; Awopeju OF; Sogaolu OM; Adewole TO; Odeyemi AO; Jiya E; Andero V; Ojo O; Toyin K; Akintomide AO; Erhabor GE
    Int J Tuberc Lung Dis; 2023 Dec; 27(12):912-917. PubMed ID: 38042968
    [No Abstract]   [Full Text] [Related]  

  • 2. Chest X ray score (Timika score): an useful adjunct to predict treatment outcome in tuberculosis.
    Chakraborthy A; Shivananjaiah AJ; Ramaswamy S; Chikkavenkatappa N
    Adv Respir Med; 2018; 86(5):205-210. PubMed ID: 30378646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial burden.
    Gopalan N; Srinivasalu VA; Chinnayan P; Velayutham B; Bhaskar A; Santhanakrishnan R; Senguttuvan T; Rathinam S; Ayyamperumal M; Satagopan K; Rajendran D; Manoharan T; Lakshmanan S; Paramasivam P; Angamuthu D; Ganesan M; Easudoss Arockia JW; Venkatesan RB; Lakshmipathy V; Shanmugham S; Subramanyam B; Shankar S; Mohideen Shaheed J; Dhanaraj B; Paranji Ramiyengar N; Swaminathan S; Chandrasekaran P
    PLoS One; 2021; 16(9):e0257647. PubMed ID: 34543329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.
    von Groote-Bidlingmaier F; Patientia R; Sanchez E; Balanag V; Ticona E; Segura P; Cadena E; Yu C; Cirule A; Lizarbe V; Davidaviciene E; Domente L; Variava E; Caoili J; Danilovits M; Bielskiene V; Staples S; Hittel N; Petersen C; Wells C; Hafkin J; Geiter LJ; Gupta R
    Lancet Respir Med; 2019 Mar; 7(3):249-259. PubMed ID: 30630778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple, valid, numerical score for grading chest x-ray severity in adult smear-positive pulmonary tuberculosis.
    Ralph AP; Ardian M; Wiguna A; Maguire GP; Becker NG; Drogumuller G; Wilks MJ; Waramori G; Tjitra E; Sandjaja ; Kenagalem E; Pontororing GJ; Anstey NM; Kelly PM
    Thorax; 2010 Oct; 65(10):863-9. PubMed ID: 20861290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial.
    Mandal P; Chalmers JD; Graham C; Harley C; Sidhu MK; Doherty C; Govan JW; Sethi T; Davidson DJ; Rossi AG; Hill AT
    Lancet Respir Med; 2014 Jun; 2(6):455-63. PubMed ID: 24717640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role and performance of chest X-ray for the diagnosis of tuberculosis: a cost-effectiveness analysis in Nairobi, Kenya.
    van Cleeff MR; Kivihya-Ndugga LE; Meme H; Odhiambo JA; Klatser PR
    BMC Infect Dis; 2005 Dec; 5():111. PubMed ID: 16343340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial.
    Wallis RS; Ginindza S; Beattie T; Arjun N; Likoti M; Edward VA; Rassool M; Ahmed K; Fielding K; Ahidjo BA; Vangu MDT; Churchyard G
    Lancet Respir Med; 2021 Aug; 9(8):897-908. PubMed ID: 33740465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial.
    Lee JK; Lee JY; Kim DK; Yoon HI; Jeong I; Heo EY; Park YS; Jo YS; Lee JH; Park SS; Park JS; Kim J; Lee SM; Joh JS; Lee CH; Lee J; Choi SM; Park JH; Lee SH; Cho YJ; Lee YJ; Kim SJ; Kwak N; Hwang YR; Kim H; Ki J; Lim JN; Choi HS; Lee M; Song T; Kim HS; Han J; Ahn H; Hahn S; Yim JJ
    Lancet Infect Dis; 2019 Jan; 19(1):46-55. PubMed ID: 30477961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of combined isoniazid-rifampicin-pyrazinamide-levofloxacin dry powder inhaler in treatment of pulmonary tuberculosis: A randomized controlled trial.
    Laohapojanart N; Ratanajamit C; Kawkitinarong K; Srichana T
    Pulm Pharmacol Ther; 2021 Oct; 70():102056. PubMed ID: 34273498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homeopathic treatment in addition to standard care in multi drug resistant pulmonary tuberculosis: a randomized, double blind, placebo controlled clinical trial.
    Chand KS; Manchanda RK; Mittal R; Batra S; Banavaliker JN; De I
    Homeopathy; 2014 Apr; 103(2):97-107. PubMed ID: 24685414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
    Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
    BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis.
    Dawson R; Diacon AH; Everitt D; van Niekerk C; Donald PR; Burger DA; Schall R; Spigelman M; Conradie A; Eisenach K; Venter A; Ive P; Page-Shipp L; Variava E; Reither K; Ntinginya NE; Pym A; von Groote-Bidlingmaier F; Mendel CM
    Lancet; 2015 May; 385(9979):1738-1747. PubMed ID: 25795076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
    Loncharich MF; Anderson CW
    ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid for drug-resistant pulmonary tuberculosis.
    Singh B; Cocker D; Ryan H; Sloan DJ
    Cochrane Database Syst Rev; 2019 Mar; 3(3):CD012836. PubMed ID: 30893466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow radiological improvement and persistent low-grade inflammation after chemotherapy in tuberculosis patients with type 2 diabetes.
    Mily A; Sarker P; Taznin I; Hossain D; Haq MA; Kamal SMM; Agerberth B; Brighenti S; Raqib R
    BMC Infect Dis; 2020 Dec; 20(1):933. PubMed ID: 33287713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Basis for treatment of tuberculosis among HIV-infected patients in Tanzania: the role of chest x-ray and sputum culture.
    Bakari M; Arbeit RD; Mtei L; Lyimo J; Waddell R; Matee M; Cole BF; Tvaroha S; Horsburgh CR; Soini H; Pallangyo K; von Reyn CF
    BMC Infect Dis; 2008 Mar; 8():32. PubMed ID: 18325120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EVALUATING THE VALIDITY AND RELIABILITY OF CHEST RADIOGRAPHY IN THE DIAGNOSIS OF TUBERCULOSIS AMONG SMEAR NEGATIVE PULMONARY TUBERCULOSIS PATIENTS.
    Tewolde E; Atnafu A; Kebede T; Tedla Y; Assefa G; Bedane A; Enquselassie F
    Ethiop Med J; 2015 Apr; 53(2):83-9. PubMed ID: 26591296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial.
    Tweed CD; Dawson R; Burger DA; Conradie A; Crook AM; Mendel CM; Conradie F; Diacon AH; Ntinginya NE; Everitt DE; Haraka F; Li M; van Niekerk CH; Okwera A; Rassool MS; Reither K; Sebe MA; Staples S; Variava E; Spigelman M
    Lancet Respir Med; 2019 Dec; 7(12):1048-1058. PubMed ID: 31732485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.